Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index
cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994).
Obes Res 1997;5:542–8.
Mokdad AH, Serdula MK, Dietz WH, et al. The continuing epidemic of obesity in
the United States. JAMA 2000;284:1650–1 [letter].
Lewis CE, Jacobs DR Jr, McCreath H, et al. Weight gain continues in the 1990s:
10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk
Development in Young Adults. Am J Epidemiol 2000;151:1172–81.
Fine JT, Colditz GA, Coakley EG, et al. A prospective study of weight change
and health-related quality of life in women. JAMA 1999;282:2136–42.
Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a
prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–105.
Salamone LM, Cauley JA, Black DM, et al. Effect of a lifestyle intervention on
bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr
1999;70:97–103.
Armstrong J, Reilly JJ, Child Health Information Team. Breastfeeding and
lowering the risk of childhood obesity. Lancet 2002;359:2003–4.
Knopp RH, Walden CE, Retzlaff BM, et al. Long-term cholesterol-lowering
effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The
Dietary Alternatives Study. JAMA 1997;278:1509–15.
Willett WC. Dietary fat and obesity: an unconvincing relation. Am J Clin
Nutr 1998;68:1149–50.
Andersson I, Lennernas M, Rossner S. Meal pattern and risk factor evaluation
in one-year completers of a weight reduction program for obese men - the ‘Gustaf’
study. J Intern Med 2000;247:30–8.
Westman EC, Yancy WS, Edman JS, et al. Effect of 6-month adherence to a very
low carbohydrate diet program. Am J Med 2002;113:30–6.
Duncan KH, Bacon JA, Weinsier RL. The effects of high and low energy density
diets on satiety, energy intake, and eating time of obese and nonobese subjects. Am J Clin
Nutr 1983;37:763–7.
Marquette CJ Jr. Effects of bulk producing tablets on hunger intensity in
dieting patients. Obes Bariatr Med 1976;5(3):84–8.
Rossner S, von Zweigbergk D, Ohlin A, Ryttig K. Weight reduction with dietary
fibre supplements. Acta Med Scand 1987;222:83–8.
Biancardi G, Palmiero L, Ghirardi PE. Glucomannan in the treatment of
overweight patients with osteoarthritis. Curr Ther Res 1989;46:908–12.
Hylander B, Rössner S. Effects of dietary fiber intake before meals on
weight loss and hunger in a weight-reducing club. Acta Med Scand
1983;213:217–20.
Randolph TG. Masked food allergy as a factor in the development and
persistence of obesity. J Lab Clin Med 1947;32:1547.
Muls E, Kempen K, Vansant G, et al. Is weight cycling detrimental to health? A
review of the literature in humans. Int J Obes 1995;19(3):S46–S50.
Roberts SB. High-glycemic index foods, hunger, and obesity: is there a
connection? Nutr Rev 2000;58:163–9 [review].
Wadden TA, Berkowitz RI, Sarwer DB, et al. Benefits of lifestyle modification
in the pharmacologic treatment of obesity. A randomized trial. Arch Intern Med
2001;161:218–27.
Racette SB, Schoeller DA, Kushner RF, Neil KM. Exercise enhances dietary
compliance during moderate energy restriction in obese women. Am J Clin Nutr
1995;62:345–9.
[No authors listed]. Effect of exercise alone on obesity. Br Med J
1976;1:417–8.
Votruba SB, Horvitz MA, Schoeller DA. The role of exercise in the treatment of
obesity. Nutrition 2000;16:179–88.
Votruba SB, Horvitz MA, Schoeller DA. The role of exercise in the treatment of
obesity. Nutrition 2000;16:179–88.
National Task Force on the Prevention and Treatment of Obesity. Dieting and
the Development of Eating Disorders in Overweight and Obese Adults. Arch Intern Med
2000;160:2581–9.
Pi-Sunyer FX. Obesity. In Shils ME, Olson JA, Shike M, Ross AC, eds.
Modern Nutrition in Health and Disease, 9th ed. Baltimore: Williams and Wilkins, 1999,
1410.
Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and
nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate. Am J Clin
Nutr 1992;56:630–5.
Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a
low-cholesterol, low-fat diet: Effects on plasma lipid concentration and body composition in
hyperlipidemic patients. Am J Clin Nutr 1994;59:423–7.
Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation
on body composition in overweight individuals. Nutrition 1999;15:337–40.
Kalman D, Colker CM, Stark S, et al. Effect of pyruvate supplementation on
body composition and mood. Curr Ther Res 1998;59:793–802.
Kreider R, Koh P, Ferreira M, et al. Effects of pyruvate supplementation
during training on body composition & metabolic responses to exercise. Med Sci Sports
Exerc 1998;30:S62 [abstract].
Ivy JL, Cortez MY, Chandler RM, et al. Effects of pyruvate on the metabolism
and insulin resistance of obese Zucker rats. Am J Clin Nutr 1994;59:331–7.
Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5-hydroxytryptophan
administration on feeding behavior in obese adult female subjects. J Neural Transm
1989;76:109–17.
Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary
prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin
Nutr 1992;56:863–7.
Cangiano C, Ceci F, Cairella M, et al. Effects of 5-hydroxytryptophan on
eating behavior and adherence to dietary prescriptions in obese adult subjects. Adv Exp
Med Biol 1991;294:591–3.
Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary
prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin
Nutr 1992;56:863–7.
Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan
on energy intake and macronutrient selection in non-insulin dependent diabetic patients.
Int J Obes Relat Metab Disord 1998;22:648–54.
Colker CM, Torina GC, Swain MA, Kalman DS. Double-blind study evaluating the
effects of exercise plus 3-acetyl-7-oxo-dehydroepiandrosterone on body composition and the
endocrine system in overweight adults. J Exercise Physiology Online 1999;2(4).
He Z-Q, Phone ZS. Body weight reduction in adolescents by a combination of
measures including using L-carnitine. Acta Nutrimenta Sinica 1997;19(2).
Becher EW, Jakober B, Luft D, et al. Clinical and biochemical evaluations of
the alga spirulina with regard to its application in the treatment of obesity. A double-blind
cross-over study. Nutr Rep Intl 1986;33:565–73.
Anderson RA. Effects of chromium on body composition and weight loss. Nutr
Rev 1998;56:266–70.
Bahadori B, Wallner S, Schneider H, et al. Effect of chromium yeast and
chromium picolinate on body composition of obese, non-diabetic patients during and after a
formula diet. Acta Med Austriaca 1997;24:185–7
Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body
composition. J Sports Med Phys Fitness 1995;35:273–80
Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis by rat
liver in vivo. J Biol Chem 1971;246:629–32.
Triscari J, Sullivan AC. Comparative effects of (-)-hydroxycitrate and
(+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in
vivo. Lipids 1977;12:357–63.
Cheema-Dhadli S, Harlperin ML, Leznoff CC. Inhibition of enzymes which
interact with citrate by (-)hydroxycitrate and 1,2,3,-tricarboxybenzene. Eur J
Biochem 1973;38:98–102.
Sullivan AC, Hamilton JG, Miller ON, et al. Inhibition of lipogenesis in rat
liver by (-)-hydroxycitrate. Arch Biochem Biophys 1972;150:183–90.
Greenwood MRC, Cleary MP, Gruen R, et al. Effect of (-)-hydroxycitrate on
development of obesity in the Zucker obese rat. Am J Physiol
1981;240:E72–8.
Sullivan AC, Triscari J. Metabolic regulation as a control for lipid
disorders. Am J Clin Nutr 1977;30:767–76.
Sullivan AC, Triscari J, Hamilton JG, et al. Effect of (-)-hydroxycitrate upon
the accumulation of lipid in the rat: I. Lipogenesis. Lipids 1974;9:121–8.
Sullivan AC, Triscari J, Hamilton JG, et al. Effect of (-)-hydroxycitrate upon
the accumulation of lipid in the rat: II. Appetite. Lipids 1974;9:129–34.
Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia
(hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
JAMA 1998;280:1596–600.
Martinet A, Hostettmann K, Schultz Y. Thermogenic effects of commercially
available plant preparations aimed at treating human obesity. Phytomedicine
1999;6:231–8.
Diamond P, Cusan L, Gomez J-L, et al. Metabolic effects of 12-month
percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J
Endocrinol 1996;150:S43–50.
Nestler JE, Barlasini CO, Clore JN, et al. Dehydroepiandrosterone reduces
serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in
normal men. J Clin Endocrinol Metab 1988;66:57–61.
Welle S, Jozefowicz R, Statt M. Failure of DHEA to influence energy and
protein metabolism in humans. J Clin Endocrinol Metab 1990;71:1259.
Usiskin KS, Butterworth S, Clore JN, et al. Lack of effect of
dehydroepiandrosterone in obese men. Int J Obes 1990;14:457–63.
Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, et al. Dehydroepiandrosterone in
morbidly obese adolescents: effects on weight, body composition, lipids, and insulin
resistance. Metabolism 1996;45:1101–15.
Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women.
Ann NY Acad Sci 1995;774:128–42.
Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different
effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J
Nutr 2003;89:239–48.
Demling RH, DeSanti L. Effect of a hypocaloric diet, increased protein intake
and resistance training on lean mass gains and fat mass loss in overweight police officers.
Ann Nutr Metab 2000;44:21–9.
Yoshioka M, St-Pierre S, Drapeau V, et al. Effects of red pepper on appetite
and energy intake. Br J Nutr 1999;82:115–23.
Yoshioka M, St-Pierre S, Suzuki M, Tremblay A. Effects of red pepper added to
high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in
Japanese women. Br J Nutr 1998;80:503–10.
Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some recent
observations. Pharmacol Rev 1986;38:179–226 [review].
Tremblay A. Obesity and health: what can we learn from intervention studies?
[abstract]. Paper presented to the Australian Society for the Study of Obesity, 8th Annual
Meeting, Sydney, 1999. ASSO Proceedings, Melbourne: ASSO, 1999, 38.
Leung A, Foster S. Encyclopedia of Common Natural Ingredients Used in
Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
293–4.
Astrup A, Breum L, Toubro S, et al. The effect and safety of an
ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on
an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord
1992;16:269–77.
Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in
catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in
humans. Am J Clin Nutr 1999;70:1040–5.
Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and
its activity for the treatment of obesity. Phytomedicine 2002;9:3–8.
Antonio J, Colker CM, Torina GC, et al. Effects of a standardized
guggulsterone phosphate supplement on body composition in overweight adults: A pilot study.
Curr Ther Res 1999;60:220–7.
Bone K. Clinical Applications of Ayurvedic and Chinese Herbs.
Warwick, Queensland, Australia: Phytotherapy Press, 1996, 103–7.
Colker CM, Kalman DS, Torina GC, et al. Effects of Citrus aurantium
extract, caffeine, and St. John’s wort on body fat loss, lipid levels, and mood states
in overweight healthy adults. Curr Ther Res 1999;60:145–53.
Turnbull WH, Thomas HG. The effect of Plantago ovata seed-containing
preparation on appetite variables, nutrient and energy intake. Int J Obes Metab
Disord 1995;19:338–42.
Werbach MR, Murray MT. Botanical Influences on Illness. Tarzana, CA:
Third Line Press, 2000, 476–80.
Martinet A, Hostettmann K, Schultz Y. Thermogenic effects of commercially
available plant preparations aimed at treating human obesity. Phytomedicine
1999;6:231–8.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine
combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial
in general practice. Int J Obes Relat Metab Disord 1994;18:99–103.
Toubro S, Astrup A, Breum L, et al. The acute and chronic effects of
ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Int J
Obes Relat Metab Disord 1993;17(suppl 3):73–7.